Sustained release of erythropoietin using biodegradable gelatin hydrogel microspheres persistently improves lower leg ischemia.

[1]  Y. Tabata,et al.  Post-infarct treatment with an erythropoietin-gelatin hydrogel drug delivery system for cardiac repair. , 2008, Cardiovascular research.

[2]  Ha Won Kim,et al.  Role of Nox2-Based NADPH Oxidase in Bone Marrow and Progenitor Cell Function Involved in Neovascularization Induced by Hindlimb Ischemia , 2008, Circulation research.

[3]  A. Hansen,et al.  IL-20 is an arteriogenic cytokine that remodels collateral networks and improves functions of ischemic hind limbs , 2007, Proceedings of the National Academy of Sciences.

[4]  Leslie A. Smith,et al.  Downloaded from http://hyper.ahajournals.org / by guest on February 23, 2013Essential Role of Endothelial Nitric Oxide Synthase in Vascular Effects of Erythropoietin , 2022 .

[5]  P. Boekstegers,et al.  Endothelial nitric oxide synthase overexpression provides a functionally relevant angiogenic switch in hibernating pig myocardium. , 2007, Journal of the American College of Cardiology.

[6]  K. Okumura,et al.  Mechanisms Underlying the Impairment of Ischemia-Induced Neovascularization in Matrix Metalloproteinase 2–Deficient Mice , 2007, Circulation research.

[7]  K. Sugamura,et al.  Important Role of Erythropoietin Receptor to Promote VEGF Expression and Angiogenesis in Peripheral Ischemia in Mice , 2007, Circulation research.

[8]  G. Takemura,et al.  Reduction of inflammatory cytokine expression and oxidative damage by erythropoietin in chronic heart failure. , 2006, Cardiovascular research.

[9]  I. Komuro,et al.  Critical Roles of Muscle-Secreted Angiogenic Factors in Therapeutic Neovascularization , 2006, Circulation research.

[10]  H. Cheung,et al.  Regulation of matrix metalloproteinase (MMP) gene expression by protein kinases. , 2006, Frontiers in bioscience : a journal and virtual library.

[11]  J. Loscalzo,et al.  Impaired Angiogenesis in Glutathione Peroxidase-1–Deficient Mice Is Associated With Endothelial Progenitor Cell Dysfunction , 2006, Circulation research.

[12]  G. Takemura,et al.  Preventive Effect of Erythropoietin on Cardiac Dysfunction in Doxorubicin-Induced Cardiomyopathy , 2006, Circulation.

[13]  M. Gassmann,et al.  Brain‐derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK‐1/‐2 and Akt pathways , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  S. Masuda,et al.  Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. , 2005, The New England journal of medicine.

[15]  W. Sessa,et al.  Endothelial nitric oxide synthase is critical for ischemic remodeling, mural cell recruitment, and blood flow reserve. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[16]  G. Gurtner,et al.  Adult vasculogenesis occurs through in situ recruitment, proliferation, and tubulization of circulating bone marrow-derived cells. , 2005, Blood.

[17]  A. Schechter,et al.  Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells. , 2004, Blood.

[18]  M. Bogoyevitch.  An update on the cardiac effects of erythropoietin cardioprotection by erythropoietin and the lessons learnt from studies in neuroprotection. , 2004, Cardiovascular research.

[19]  Ying Wang,et al.  Treatment of Stroke With Erythropoietin Enhances Neurogenesis and Angiogenesis and Improves Neurological Function in Rats , 2004, Stroke.

[20]  S. Meloche,et al.  Dual Regulation of MMP-2 Expression by the Type 1 Insulin-like Growth Factor Receptor , 2004, Journal of Biological Chemistry.

[21]  D. Fliser,et al.  Erythropoietin regulates endothelial progenitor cells. , 2004, Blood.

[22]  B. Carlson,et al.  Regeneration in grafts of normal and denervated rat muscles , 2004, Pflügers Archiv.

[23]  Richard B. Thompson,et al.  A novel protective effect of erythropoietin in the infarcted heart. , 2003, The Journal of clinical investigation.

[24]  C. Heeschen,et al.  Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. , 2003, Blood.

[25]  N. Ferrara,et al.  The biology of VEGF and its receptors , 2003, Nature Medicine.

[26]  P. Carmeliet.  Angiogenesis in health and disease , 2003, Nature Medicine.

[27]  Pietro Ghezzi,et al.  Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[28]  B. Carlson.  Muscle regeneration in amphibians and mammals: Passing the torch , 2003, Developmental dynamics : an official publication of the American Association of Anatomists.

[29]  A. Whittemore.  Presidential address: a team for the 21st century: the vascular center. , 2000, Journal of vascular surgery.

[30]  R. Rutherford,et al.  Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). , 2000, Journal of vascular surgery.

[31]  Y. Ikada,et al.  Surfactant-Free Preparation of Biodegradable Hydrogel Microspheres for Protein Release , 1999 .

[32]  J. Isner,et al.  Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. , 1999, Circulation research.

[33]  R. Busse,et al.  Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation , 1999, Nature.

[34]  Hiroshi Takahashi,et al.  Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferon , 1999, Nature Medicine.

[35]  Haruchika Masuda,et al.  Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization , 1999, Nature Medicine.

[36]  D. Ribatti,et al.  Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. , 1999, Blood.

[37]  S. Weiss,et al.  Matrix Metalloproteinases Regulate Neovascularization by Acting as Pericellular Fibrinolysins , 1998, Cell.

[38]  W. Schaper,et al.  Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. , 1998, The Journal of clinical investigation.

[39]  S Amerini,et al.  Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. , 1994, The Journal of clinical investigation.

[40]  H. Lodish,et al.  Structure, function, and activation of the erythropoietin receptor. , 1993, Blood.

[41]  Geoffrey Burnstock,et al.  Roles of P2‐Purinoceptors in the Cardiovascular System , 1991, Circulation.

[42]  D. Clement.  Second European Consensus Document on chronic critical leg ischemia. , 1991, Circulation.

[43]  Thomas K. Hunt,et al.  ON THE TREATMENT OF , 1846 .